FDA — authorised 22 September 2015
- Application: NDA207981
- Marketing authorisation holder: TAIHO ONCOLOGY
- Status: supplemented
FDA authorised Lonsurf on 22 September 2015
Yes. FDA authorised it on 22 September 2015; FDA has authorised it.
TAIHO ONCOLOGY holds the US marketing authorisation.